The Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice

Immunology and Microbiology

• Monoclonal Antibody 100%
• Titer 100%
• Attenuated Vaccine 100%
• Live Vaccine 100%
• Isotype 100%
• Humoral Immunity 50%
• Adoptive Immunity 50%
• T Cell 50%
• Immune Response 50%
• Memory B Cell 50%
• Yersinia Pestis 50%
• Antigen Specificity 50%
• Memory T Cell 50%
• Preclinical Study 50%
• Cell Population 50%
• B Cell 50%
• Antigen 50%
• LcrV 50%
• Adenovirus Vector 50%
• Neutralizing Antibody 50%
• Th17 Cell 50%
• Bronchoalveolar Lavage Fluid 50%
• Germinal Center 50%
• Immunoglobulin A 50%
• Cell Activity 50%
• Interleukin 2 50%
• Immunodeficiency 50%
• Antimicrobial Agent 50%
• Lethal Dose 50%

Keyphrases

• Pneumonic Plague 100%
• Vaccine Strategy 100%
• Protective Effect 100%
• Interleukin-17 (IL-17) 100%
• Immunization Strategy 100%
• Y. Pestis 60%
• Immunization 40%
• IL-17A Monoclonal Antibody 40%
• Humoral Immune Response 20%
• Cellular Immune Response 20%
• Immune Response 20%
• Plague 20%
• Public Health Risk 20%
• Vaccination 20%
• Immunological Response 20%
• Live Attenuated 20%
• Yersinia Pestis 20%
• Biothreat Agents 20%
• Memory T Cells 20%
• Antigen-specific T Cells 20%
• Live Attenuated Vaccine 20%
• Cell Population 20%
• Spleen 20%
• B Cells 20%
• Severe Disease 20%
• LcrV 20%
• Adenovirus Vaccine 20%
• Immune Deficiency 20%
• Complete Protection 20%
• Bronchoalveolar Lavage Fluid 20%
• Th1 Response 20%
• Lethal Dose 20%
• Trivalent 20%
• IgG Isotypes 20%
• Germinal Center 20%
• Th17 Response 20%
• Antibody Isotypes 20%
• Titer 20%
• Neutralizing Antibodies 20%
• Cell Activity 20%
• Interleukin-2 20%
• IgG Titer 20%
• Response to Vaccination 20%
• Serum IgG 20%
• Prophylactic Antibiotics 20%
• Isotype Control 20%
• Challenge Dose 20%
• Intranasal Challenge 20%
• Mucosal IgA 20%
• Oligoclonal IgG Bands 20%
• Memory B Cells 20%
• T Helper 17 Cells (Th17) 20%
• Reduced Serum 20%